Condition

Arrhythmogenic Cardiomyopathy clinical trials and research

• 8Clinical trials
• 7Countries

Newest Arrhythmogenic Cardiomyopathy clinical trials

All recruiting trials (8)

• S-ICD Eligibility Over Time in Arrhythmogenic Cardiomyopathy

  This study checks whether adults with arrhythmogenic cardiomyopathy stay eligible for a subcutaneous ICD over 18 months.

  Recruiting University of Sao Paulo · São Paulo, São Paulo · NCT07849764

• T1 mapping to characterize heart tissue in common heart diseases

  This project tests whether T1 mapping MRI scans, including dye-free native T1, can define normal and disease-specific heart tissue values for adults with various heart conditions.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing, Beijing Municipality · NCT07354646

• Assessing patient characteristics and clinical course for those with PKP2-ACM

  This study looks at the experiences and health changes of people with PKP2-ACM over time to better understand the condition and its impact on their lives.

  Recruiting at 6 sites Lexeo Therapeutics · Redwood City, California and 5 other locations · NCT06976606

• Atorvastatin 80 mg to slow progression of arrhythmogenic cardiomyopathy

  This trial will try daily high-dose atorvastatin (80 mg) versus placebo in adults with arrhythmogenic cardiomyopathy to see if it prevents right ventricular functional decline and related electrical and structural worsening.

  Recruiting at 4 sites Phase 2 Centro Cardiologico Monzino · Pavia, PV and 4 other locations · NCT06922994

• Identifying patients with cardiomyopathy for potential heart transplantation

  This study is trying to find new ways to identify and understand cardiomyopathy in patients to better predict if they might need a heart transplant in the future.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Emilia-Romagna/Bologna and 2 other locations · NCT06813443

• Predicting Ventricular Tachycardia Events in Patients with Non-Ischemic Cardiomyopathy

  This study is trying to see if certain heart imaging tests can help predict the risk of dangerous heart rhythms and sudden cardiac death in people with non-ischemic cardiomyopathy.

  Recruiting at 4 sites Centro Medico Teknon · Milan, Italy and 3 other locations · NCT06730464

• Understanding Arrhythmogenic Cardiomyopathy and its Treatment

  This study is trying to learn more about Arrhythmogenic Cardiomyopathy by collecting health information and samples from patients to see how the condition behaves and what the long-term outcomes are.

  Recruiting First Affiliated Hospital Xi'an Jiaotong University · Xi'an, Shaanxi · NCT06352307

• Targeted therapy for arrhythmogenic cardiomyopathy using tideglusib

  This study is testing a new medication called tideglusib to see if it can help people with a specific genetic type of arrhythmogenic cardiomyopathy feel better and reduce their risk of serious heart problems.

  Recruiting at 10 sites Phase 2 Hamilton Health Sciences Corporation · Calgary, Alberta and 16 other locations · NCT06174220

Related topics

Quick answers

How many Arrhythmogenic Cardiomyopathy clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in Italy (3 trials), China (2 trials), United States (1 trial), Brazil (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →